Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREDEX study of exenatide protection against prednisolone-induced glucose impairment
NL-OMON33811Active, not recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Jan 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial in corticosteroid-induced hyperglycemia (GIH) and steroid-induced diabetes mellitus (SIDM) comparing Placebo + saline infusion, Prednisolone + saline infusion and Prednisolone + exenatide infusion (3 arms). Primary endpoint: Glucose tolerance during standardized mixed-meal test. Started Jan 2009; status: active, not recruiting.
02
Drugs
exenatideprednisolone
03
Conditions
corticosteroid-induced hyperglycemia (GIH)steroid-induced diabetes mellitus (SIDM)
Beyond the preview
Go deeper on NL-OMON33811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33811.